announcements & circulars-凯发88
english
凯发88-凯发vip-娱乐凯发app下载
中文繁体
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
company
overview
board of directors
scientific advisory board
partnering
core competence
technology
bispecific
mix-mab
biologics manufacturing
publications
pipeline
overview
envafolimab(kn035)
kn046
kn026
kn026 kn046
kn019
investors
information disclosure
corporate governance
stock information
ir contacts
email subscription
news
press release
media report
career
corporate culture
job opportunities
contact us
english
凯发88-凯发vip-娱乐凯发app下载
中文繁体
investors
information disclosure
listing documents
financial reports
announcements & circulars
company presentation
corporate governance
stock information
ir contacts
email subscription
announcements & circulars
the announcement begins in december 2019
change of independent non-executive director
2021-08-27
voluntary announcement - exclusive collaboration with cspc in relation to the development and commercialization of kn026 in mainland china
2021-08-23
date of board meeting
2021-08-16
monthly return of equity issuer on movements in securities for the month ended 31 july 2021
2021-08-05
voluntary announcement - abstracts and e-posters of research updates on kn046 and kn026 for presentation at esmo congress 2021
2021-07-26
monthly return of equity issuer on movements in securities for the month ended 30 june 2021
2021-07-06
poll results of annual general meeting held on june 11, 2021
2021-06-11
monthly return of equity issuer on movements in securities for the month ended 31 may 2021
2021-06-03
connected transaction announcement - technology development collaboration with suzhou alphamab on jskn003 project and kn062 covid-19 antibody project
2021-05-27
next day disclosure return
2021-05-26
1
2
3
4
5
6
prev
3/11
next
网站地图